Sari Niinistö1, Hanna-Mari Takkinen2,3, Iris Erlund2, Suvi Ahonen2,3,4, Jorma Toppari5,6, Jorma Ilonen7, Riitta Veijola8, Mikael Knip9,10,11,12, Outi Vaarala10, Suvi M Virtanen2,3,4,12. 1. Department of Public Health Solutions, National Institute for Health and Welfare, PO Box 30, FI-00271, Helsinki, Finland. sari.niinisto@thl.fi. 2. Department of Public Health Solutions, National Institute for Health and Welfare, PO Box 30, FI-00271, Helsinki, Finland. 3. The Faculty of Social Sciences, University of Tampere, Tampere, Finland. 4. Science Center, Tampere University Hospital, Tampere, Finland. 5. Department of Physiology, Institute of Biomedicine, University of Turku, Turku, Finland. 6. Department of Pediatrics, Turku University Hospital, Turku, Finland. 7. Immunogenetics Laboratory, University of Turku, Turku, Finland. 8. Department of Pediatrics, PEDEGO Research Unit, Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland. 9. Children's Hospital, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. 10. Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland. 11. Folkhälsan Research Center, Helsinki, Finland. 12. Center for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland.
Abstract
AIMS/HYPOTHESIS: We investigated the association of early serum fatty acid composition with the risk of type 1 diabetes-associated autoimmunity. Our hypothesis was that fatty acid status during infancy is related to type 1 diabetes-associated autoimmunity and that long-chain n-3 fatty acids, in particular, are associated with decreased risk. METHODS: We performed a nested case-control analysis within the Finnish Type 1 Diabetes Prediction and Prevention Study birth cohort, carrying HLA-conferred susceptibility to type 1 diabetes (n = 7782). Serum total fatty acid composition was analysed by gas chromatography in 240 infants with islet autoimmunity and 480 control infants at the age of 3 and 6 months. Islet autoimmunity was defined as repeated positivity for islet cell autoantibodies in combination with at least one of three selected autoantibodies. In addition, a subset of 43 infants with primary insulin autoimmunity (i.e. those with insulin autoantibodies as the first autoantibody with no concomitant other autoantibodies) and a control group (n = 86) were analysed. A third endpoint was primary GAD autoimmunity defined as GAD autoantibody appearing as the first antibody without other concomitant autoantibodies (22 infants with GAD autoimmunity; 42 infants in control group). Conditional logistic regression was applied, considering multiple comparisons by false discovery rate <0.05. RESULTS: Serum fatty acid composition differed between breastfed and non-breastfed infants, reflecting differences in the fatty acid composition of the milk. Fatty acids were associated with islet autoimmunity (higher serum pentadecanoic, palmitic, palmitoleic and docosahexaenoic acids decreased risk; higher arachidonic:docosahexaenoic and n-6:n-3 acid ratios increased risk). Furthermore, fatty acids were associated with primary insulin autoimmunity, these associations being stronger (higher palmitoleic acid, cis-vaccenic, arachidonic, docosapentaenoic and docosahexaenoic acids decreased risk; higher α-linoleic acid and arachidonic:docosahexaenoic and n-6:n-3 acid ratios increased risk). Moreover, the quantity of breast milk consumed per day was inversely associated with primary insulin autoimmunity, while the quantity of cow's milk consumed per day was directly associated. CONCLUSIONS/ INTERPRETATION: Fatty acid status may play a role in the development of type 1 diabetes-associated autoimmunity. Fish-derived fatty acids may be protective, particularly during infancy. Furthermore, fatty acids consumed during breastfeeding may provide protection against type 1 diabetes-associated autoimmunity. Further studies are warranted to clarify the independent role of fatty acids in the development of type 1 diabetes.
AIMS/HYPOTHESIS: We investigated the association of early serum fatty acid composition with the risk of type 1 diabetes-associated autoimmunity. Our hypothesis was that fatty acid status during infancy is related to type 1 diabetes-associated autoimmunity and that long-chain n-3 fatty acids, in particular, are associated with decreased risk. METHODS: We performed a nested case-control analysis within the Finnish Type 1 Diabetes Prediction and Prevention Study birth cohort, carrying HLA-conferred susceptibility to type 1 diabetes (n = 7782). Serum total fatty acid composition was analysed by gas chromatography in 240 infants with islet autoimmunity and 480 control infants at the age of 3 and 6 months. Islet autoimmunity was defined as repeated positivity for islet cell autoantibodies in combination with at least one of three selected autoantibodies. In addition, a subset of 43 infants with primary insulin autoimmunity (i.e. those with insulin autoantibodies as the first autoantibody with no concomitant other autoantibodies) and a control group (n = 86) were analysed. A third endpoint was primary GAD autoimmunity defined as GAD autoantibody appearing as the first antibody without other concomitant autoantibodies (22 infants with GAD autoimmunity; 42 infants in control group). Conditional logistic regression was applied, considering multiple comparisons by false discovery rate <0.05. RESULTS: Serum fatty acid composition differed between breastfed and non-breastfed infants, reflecting differences in the fatty acid composition of the milk. Fatty acids were associated with islet autoimmunity (higher serum pentadecanoic, palmitic, palmitoleic and docosahexaenoic acids decreased risk; higher arachidonic:docosahexaenoic and n-6:n-3 acid ratios increased risk). Furthermore, fatty acids were associated with primary insulin autoimmunity, these associations being stronger (higher palmitoleic acid, cis-vaccenic, arachidonic, docosapentaenoic and docosahexaenoic acids decreased risk; higher α-linoleic acid and arachidonic:docosahexaenoic and n-6:n-3 acid ratios increased risk). Moreover, the quantity of breast milk consumed per day was inversely associated with primary insulin autoimmunity, while the quantity of cow's milk consumed per day was directly associated. CONCLUSIONS/ INTERPRETATION:Fatty acid status may play a role in the development of type 1 diabetes-associated autoimmunity. Fish-derived fatty acids may be protective, particularly during infancy. Furthermore, fatty acids consumed during breastfeeding may provide protection against type 1 diabetes-associated autoimmunity. Further studies are warranted to clarify the independent role of fatty acids in the development of type 1 diabetes.
Entities:
Keywords:
Autoimmunity; Breast milk; Fatty acid status; Infant; Type 1 diabetes; n-3 fatty acids
Authors: Liisa Uusitalo; Jaakko Nevalainen; Irma Salminen; Marja-Leena Ovaskainen; Carina Kronberg-Kippilä; Suvi Ahonen; Sari Niinistö; Georg Alfthan; Olli Simell; Jorma Ilonen; Riitta Veijola; Mikael Knip; Suvi M Virtanen Journal: Matern Child Nutr Date: 2011-11-08 Impact factor: 3.092
Authors: Nicolai A Lund-Blix; Lars C Stene; Trond Rasmussen; Peter A Torjesen; Lene F Andersen; Kjersti S Rønningen Journal: Diabetes Care Date: 2014-11-24 Impact factor: 19.112
Authors: T Kimpimäki; P Kulmala; K Savola; P Vähäsalo; H Reijonen; J Ilonen; H K Akerblom; M Knip Journal: J Clin Endocrinol Metab Date: 2000-03 Impact factor: 5.958
Authors: Kendra Vehik; Kristian F Lynch; Desmond A Schatz; Beena Akolkar; William Hagopian; Marian Rewers; Jin-Xiong She; Olli Simell; Jorma Toppari; Anette-G Ziegler; Åke Lernmark; Ezio Bonifacio; Jeffrey P Krischer Journal: Diabetes Care Date: 2016-06-16 Impact factor: 17.152
Authors: Matej Oresic; Peddinti Gopalacharyulu; Juha Mykkänen; Niina Lietzen; Marjaana Mäkinen; Heli Nygren; Satu Simell; Ville Simell; Heikki Hyöty; Riitta Veijola; Jorma Ilonen; Marko Sysi-Aho; Mikael Knip; Tuulia Hyötyläinen; Olli Simell Journal: Diabetes Date: 2013-04-29 Impact factor: 9.461
Authors: C Ricordi; M Clare-Salzler; M Infante; C Baggerly; J Aliano; S McDonnell; S Chritton Journal: CellR4 Repair Replace Regen Reprogram Date: 2019-08-28
Authors: Randi K Johnson; Lauren A Vanderlinden; Brian C DeFelice; Ulla Uusitalo; Jennifer Seifert; Sili Fan; Tessa Crume; Oliver Fiehn; Marian Rewers; Katerina Kechris; Jill M Norris Journal: Pediatr Diabetes Date: 2020-08-09 Impact factor: 4.866
Authors: Teresa Buckner; Lauren A Vanderlinden; Brian C DeFelice; Patrick M Carry; Katerina Kechris; Fran Dong; Oliver Fiehn; Brigitte I Frohnert; Michael Clare-Salzler; Marian Rewers; Jill M Norris Journal: Diabetologia Date: 2021-04-24 Impact factor: 10.460
Authors: Ling Xiao; Belinda Van't Land; Wouter R P H van de Worp; Bernd Stahl; Gert Folkerts; Johan Garssen Journal: Front Immunol Date: 2017-09-28 Impact factor: 7.561
Authors: Essi Syrjälä; Jaakko Nevalainen; Jaakko Peltonen; Hanna-Mari Takkinen; Leena Hakola; Mari Åkerlund; Riitta Veijola; Jorma Ilonen; Jorma Toppari; Mikael Knip; Suvi M Virtanen Journal: Sci Rep Date: 2019-05-23 Impact factor: 4.379